2023
DOI: 10.1016/j.vaccine.2023.07.016
|View full text |Cite
|
Sign up to set email alerts
|

Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
references
References 35 publications
0
0
0
Order By: Relevance